Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 17

Single Port Robotic System for Pediatric Surgery

Official title: Use of the Single Port Robotic System in Pediatric Surgery

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07660497 · Data updated 2026-11-12

This study tests whether the Single Port robotic system can be safely used to perform certain pediatric abdominal surgeries (like pyeloplasty and reflux procedures) in children aged 1 to 17.

Quick facts

Study typeInterventional
Ages1 Year to 17 Years
SexAll
Enrollment10 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations1 site (Saint-Etienne)
StatusRecruiting
StartedNovember 14, 2025
Main results expectedDecember 1, 2026
Study endsDecember 15, 2026
Registry record updatedJune 22, 2026
Trial IDNCT07660497 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 1 to 17 who need abdominal surgery such as pyeloplasty, vesicoureteral reflux surgery, or gastroesophageal reflux treatment and have consent from guardians.

Probably not a fit

Patients who have contraindications to robotic surgery or who require multiple prior abdominal surgeries may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study aims to assess the feasibility of using a single-port robotic platform for pediatric abdominal procedures, including pyeloplasty, ureterovesical reimplantation, and gastroesophageal reflux treatment. It builds on prior robotic approaches by substituting a single access port for multiple trocars, potentially reducing invasiveness. Patients are children and adolescents requiring abdominal surgery at Saint-Etienne University Hospital, with involvement limited to those meeting specific age and consent criteria. Outcomes focus on technical feasibility, safety, and perioperative performance of the single-port system. The trial is conducted under a non-randomized, interventional framework at a single center with a defined lead sponsor.

Why it matters

Potential benefit: If successful, children could experience less surgical trauma and faster recovery with the single-port robotic approach.

How similar studies have gone: Robotic single-port concepts have shown feasibility in adults; pediatric data are limited, making this investigation relatively novel but informed by related robotic approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 10 and 17 inclusive for the first five and between 1 and 17 for the next five
* Parents or guardians affiliated with or entitled to social security
* Patient and legal representative of the patient who has received informed information about the study and has signed the consent form for the child's participation in the study.
* Patients seen in paediatric surgery consultations at Saint-Etienne University Hospital
* Patient requiring abdominal surgery such as pyeloplasty, vesicoureteral reflux or gastro-oesophageal reflux

Exclusion Criteria:

* History of haemorrhagic disease
* History of multiple abdominal surgeries (as intraperitoneal adhesions can make surgical access difficult)
* Pregnant adolescents
* Patients with electronic implants (e.g. pacemakers).
* Parents or guardians under guardianship or trusteeship.

Where it's running

  • Chu de Saint-Etienne Hopital Nord
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.